rs201523857
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000370695.8(SLC9A6):āc.25G>Cā(p.Ala9Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000265 in 1,130,890 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A9S) has been classified as Benign.
Frequency
Consequence
ENST00000370695.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A6 | NM_001379110.1 | c.-57+50G>C | intron_variant | ENST00000630721.3 | NP_001366039.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A6 | ENST00000630721.3 | c.-57+50G>C | intron_variant | 4 | NM_001379110.1 | ENSP00000487486 |
Frequencies
GnomAD3 genomes AF: 0.00000900 AC: 1AN: 111154Hom.: 0 Cov.: 22 AF XY: 0.0000300 AC XY: 1AN XY: 33376
GnomAD3 exomes AF: 0.0000231 AC: 2AN: 86554Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 14414
GnomAD4 exome AF: 0.00000196 AC: 2AN: 1019736Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 320412
GnomAD4 genome AF: 0.00000900 AC: 1AN: 111154Hom.: 0 Cov.: 22 AF XY: 0.0000300 AC XY: 1AN XY: 33376
ClinVar
Submissions by phenotype
Christianson syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 03, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 22, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 9 of the SLC9A6 protein (p.Ala9Pro). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC9A6-related conditions. This missense change has been observed to be homozygous or hemizygous in an individual who did not have the expected clinical features for that genetic result (Invitae). ClinVar contains an entry for this variant (Variation ID: 1030062). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at